Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis.
Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis.
复制标题
DOI:
10.1097/gim.0b013e318204d004
复制
发表时间:
2011-04
期刊:
影响因子:
--
通讯作者:
Benatar M
中科院分区:
文献类型:
--
作者:
Fanos JH;Gronka S;Wuu J;Stanislaw C;Andersen PM;Benatar M
Pre-fALS is a longitudinal study of individuals potentially at risk for developing familial amyotrophic lateral sclerosis (fALS). Our goals were to: 1) explore participants’ decisions whether or not to learn results of pre-symptomatic testing; 2) understand the psychosocial impact of these decisions; 3) assess preferences for receiving results by telephone or in-person. The sample for this sub-study comprised 20 participants drawn randomly from autosomal dominant mutant SOD1 (mtSOD1) families in the Pre-fALS study. Twenty participants completed a semi-structured phone interview; prominent themes were identified and rated. Fourteen participants chose to learn results; 6 had mtSOD1 and 8 had wtSOD1. Of the 6 who initially elected non-disclosure, 3 were reconsidering their decision. Regardless of the results and method of counseling, participants had adapted well, at least in the short-term. We recommend: 1) those considering pre-symptomatic genetic testing should undergo professional counseling to help decide whether to learn results; 2) discussion should include the option of telephone genetic counseling for those without easy access to in-person counseling; 3) those who initially decline to learn results should be offered the opportunity to learn their mutation status as their decision evolves.